{"id":"zonegran","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Somnolence","drugRate":"","severity":"common","organSystem":""},{"effect":"Anorexia","drugRate":"","severity":"common","organSystem":""},{"effect":"Dizziness","drugRate":"","severity":"common","organSystem":""},{"effect":"Ataxia","drugRate":"","severity":"common","organSystem":""},{"effect":"Agitation/Irritability","drugRate":"","severity":"common","organSystem":""},{"effect":"Difficulty with memory and/or concentration","drugRate":"","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea/Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Weight loss","drugRate":"","severity":"common","organSystem":""},{"effect":"Mental slowing","drugRate":"","severity":"common","organSystem":""},{"effect":"Accidental injury","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Asthenia","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Tremor","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Convulsion","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Abnormal gait","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Hyperesthesia","drugRate":"","severity":"frequent","organSystem":""},{"effect":"Incoordination","drugRate":"","severity":"frequent","organSystem":""}],"contraindications":["Agranulocytosis","Aplastic anemia","Depressive disorder","Diarrhea","Diminished sweating","Disease of liver","Fever","Kidney disease","Kidney stone","Metabolic acidosis","Mood swings","Psychotic disorder","Severe chronic obstructive pulmonary disease","Suicidal thoughts","Surgical procedure"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Lupus erythematosus","drugRate":"","severity":"serious"},{"effect":"Pulmonary embolus","drugRate":"","severity":"serious"},{"effect":"Heart failure","drugRate":"","severity":"serious"},{"effect":"Atrial fibrillation","drugRate":"","severity":"serious"},{"effect":"Thrombocytopenia","drugRate":"","severity":"serious"},{"effect":"Cholestatic jaundice","drugRate":"","severity":"serious"},{"effect":"Hematemesis","drugRate":"","severity":"serious"},{"effect":"Hyponatremia","drugRate":"","severity":"serious"},{"effect":"Syncope","drugRate":"","severity":"serious"},{"effect":"Thrombophlebitis","drugRate":"","severity":"serious"}]},"trials":[],"_chembl":null,"aliases":["zonisamide"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"d12de43e-3ac3-4335-bc85-70d7366a91eb","title":"ZONEGRAN (ZONISAMIDE) CAPSULE [ADVANZ PHARMA (US) CORP.]"},"ecosystem":[],"mechanism":{"target":"Amine oxidase [flavin-containing] B, Carbonic anhydrase 1, Carbonic anhydrase 12"},"_scrapedAt":"2026-03-27T23:39:56.120Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Diffuse Lewy body disease","diseaseId":"diffuse-lewy-body-disease","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Partial Epilepsy Treatment Adjunct","diseaseId":"partial-epilepsy-treatment-adjunct","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06534502","phase":"PHASE4","title":"Study of the Pharmacokinetics, Safety, and Tolerability of ZONISADE in Children 1 Month to 17 Years of Age With Partial-onset Seizures","status":"NOT_YET_RECRUITING","sponsor":"Azurity Pharmaceuticals","startDate":"2026-07","conditions":"Seizures, Seizures, Focal, Seizure, Partial Onset","enrollment":40},{"nctId":"NCT04774250","phase":"PHASE2","title":"Noise-Induced Hearing Loss-Acute Exposure Treatment (UA)","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-11-10","conditions":"Hearing Loss, Noise-Induced","enrollment":3},{"nctId":"NCT05205811","phase":"PHASE3","title":"The Effects of Combination Zonisamide and Bupropion on Switching to an Electronic Cigarette","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2021-12-14","conditions":"Smoking Cessation","enrollment":180},{"nctId":"NCT03196466","phase":"","title":"Population Pharmacokinetics of Antiepileptic in Pediatrics","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2017-06-19","conditions":"Epilepsy","enrollment":753},{"nctId":"NCT03689114","phase":"PHASE4","title":"Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2021-05-10","conditions":"Epilepsies, Partial","enrollment":58},{"nctId":"NCT06967012","phase":"PHASE4","title":"A Clinical Study on the Efficacy and Safety of Zonisamide as a First Add-On Treatment in Epileptic Seizures","status":"RECRUITING","sponsor":"Affiliated Hospital of Nantong University","startDate":"2024-08-01","conditions":"Epilepsies, Partial, Epilepsy, Tonic-Clonic","enrollment":30},{"nctId":"NCT04768569","phase":"PHASE2","title":"Noise-Induced Hearing Loss-Acute Exposure Treatment","status":"TERMINATED","sponsor":"Washington University School of Medicine","startDate":"2021-10-04","conditions":"Hearing Loss, Noise-Induced","enrollment":24},{"nctId":"NCT05134857","phase":"PHASE2","title":"The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study","status":"RECRUITING","sponsor":"Washington State University","startDate":"2022-01-07","conditions":"Alcohol Use Disorder (AUD)","enrollment":205},{"nctId":"NCT06347497","phase":"PHASE3","title":"Zonisamide Versus Topiramate in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-04-01","conditions":"Migraine","enrollment":600},{"nctId":"NCT00650052","phase":"PHASE1","title":"Fasting Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-11","conditions":"Healthy","enrollment":107},{"nctId":"NCT06361446","phase":"PHASE3","title":"Zonisamide Versus Propranolol in Migraine","status":"RECRUITING","sponsor":"Kafrelsheikh University","startDate":"2024-03-29","conditions":"Migraine","enrollment":600},{"nctId":"NCT00649714","phase":"PHASE1","title":"Fed Study of Zonisamide Capsules 100 mg and Zonegran® Capsules 100 mg","status":"COMPLETED","sponsor":"Mylan Pharmaceuticals Inc","startDate":"2003-12","conditions":"Healthy","enrollment":110},{"nctId":"NCT06374966","phase":"","title":"Real-world Study of Efficacy and Safety of Zonisamide in add-on Therapy for Patients With Focal Epilepsy","status":"NOT_YET_RECRUITING","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2024-04","conditions":"Epilepsies, Partial","enrollment":400},{"nctId":"NCT05940935","phase":"","title":"The Relationship of Developing Metabolic Acidosis With Antiepleptic Drugs in Craniotomy Operations","status":"COMPLETED","sponsor":"Trakya University","startDate":"2023-05-22","conditions":"Metabolic Acidosis, Antiepileptic Drugs, Craniotomy","enrollment":35},{"nctId":"NCT02901041","phase":"PHASE3","title":"Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism","status":"COMPLETED","sponsor":"Boston University Charles River Campus","startDate":"2017-09-21","conditions":"Alcohol Dependence","enrollment":81},{"nctId":"NCT01830868","phase":"","title":"A Post-marketing Observational Study Of The Use Of Zonisamide (ZNS) in the Adjunctive Treatment Of Adult Patients With Partial Onset Seizures (Study E2090-E044-410) (ZOOM)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2012-03","conditions":"Partial Onset Seizures","enrollment":104},{"nctId":"NCT04182399","phase":"NA","title":"Role of Zonisamide in Advanced Parkinson's Disease (PD) in Egyptian Population: Pilot Study","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2020-04-01","conditions":"Parkinson Disease","enrollment":69},{"nctId":"NCT02900352","phase":"PHASE3","title":"Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action","status":"COMPLETED","sponsor":"Virginia Commonwealth University","startDate":"2016-10","conditions":"Alcohol Use Disorder","enrollment":156},{"nctId":"NCT03636958","phase":"NA","title":"Efficacy and Safety of Perampanel in Combination in Glioma-refractory Epilepsy","status":"WITHDRAWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2021-02-15","conditions":"Refractory Epilepsy","enrollment":""},{"nctId":"NCT01766128","phase":"PHASE2, PHASE3","title":"Study of Zonisamide in Early Parkinson Disease","status":"WITHDRAWN","sponsor":"Mazandaran University of Medical Sciences","startDate":"2013-02","conditions":"Parkinson Disease","enrollment":""},{"nctId":"NCT04388319","phase":"PHASE3","title":"Zonisamide/Bupropion Effects on Switching to Electronic Cigarettes","status":"COMPLETED","sponsor":"Rose Research Center, LLC","startDate":"2020-05-27","conditions":"Smoking Cessation","enrollment":26},{"nctId":"NCT05236166","phase":"NA","title":"Multicentre Study on Rapid Versus Slow Withdrawal of Antiepileptic Monotherapy","status":"COMPLETED","sponsor":"University Magna Graecia","startDate":"2017-04-26","conditions":"Epilepsy","enrollment":48},{"nctId":"NCT01127256","phase":"PHASE4","title":"Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation","status":"COMPLETED","sponsor":"Eisai Korea Inc.","startDate":"2006-05-31","conditions":"Epilepsy","enrollment":200},{"nctId":"NCT01140867","phase":"PHASE4","title":"Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy","status":"COMPLETED","sponsor":"Eisai Korea Inc.","startDate":"2008-02-29","conditions":"Epilepsy","enrollment":121},{"nctId":"NCT03034538","phase":"PHASE4","title":"An Open-Label Tolerability and Exploratory Efficacy Study of Zonisamide for Dyskinesias in Parkinson's Disease","status":"SUSPENDED","sponsor":"The Cooper Health System","startDate":"2016-04-08","conditions":"Parkinson Disease, Parkinsonism, Dyskinesias","enrollment":20},{"nctId":"NCT04939675","phase":"NA","title":"Modification of Epilepsy Screen Questionnaire and Treatment Feasibility Evaluation","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2021-07-01","conditions":"Epilepsy","enrollment":40},{"nctId":"NCT03376139","phase":"PHASE2","title":"Zonisamide Outpatient Study","status":"WITHDRAWN","sponsor":"Pharmacotherapies for Alcohol and Substance Use Disorders Alliance","startDate":"2019-03-01","conditions":"Post Traumatic Stress Disorder, Alcohol Use Disorder","enrollment":""},{"nctId":"NCT00855738","phase":"PHASE4","title":"A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-05","conditions":"Focal Epilepsy","enrollment":111},{"nctId":"NCT00777218","phase":"NA","title":"Cognitive Side Effects of Commonly Prescribed Medications in Pediatric Migraine","status":"WITHDRAWN","sponsor":"University of South Alabama","startDate":"2007-08","conditions":"Migraine","enrollment":""},{"nctId":"NCT02368431","phase":"PHASE3","title":"Effectiveness of Zonisamide in Alcohol Dependent Veterans","status":"TERMINATED","sponsor":"VA Office of Research and Development","startDate":"2015-03-01","conditions":"Alcohol Use Disorder","enrollment":92},{"nctId":"NCT02707965","phase":"PHASE1","title":"Characterization of Epilepsy Patients BEEP 2b","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2017-06-08","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT01847469","phase":"PHASE2","title":"Zonisamide in Addition to E-CPT-C for Veterans With PTSD and Comorbid Alcohol Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2013-06","conditions":"Alcohol Dependence, Post-Traumatic Stress Disorder (PTSD)","enrollment":24},{"nctId":"NCT00404248","phase":"PHASE1, PHASE2","title":"Tetra-O-Methyl Nordihydroguaiaretic Acid in Treating Patients With Recurrent High-Grade Glioma","status":"COMPLETED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2007-01","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT01713946","phase":"PHASE3","title":"A Placebo-controlled Study of Efficacy & Safety of 2 Trough-ranges of Everolimus as Adjunctive Therapy in Patients With Tuberous Sclerosis Complex (TSC) & Refractory Partial-onset Seizures","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2013-04-29","conditions":"Tuberous Sclerosis Complex-associated Refractory Seizures","enrollment":366},{"nctId":"NCT01685996","phase":"PHASE1, PHASE2","title":"Zonisamide Augmentation of Varenicline Treatment for Smoking Cessation","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2012-09","conditions":"Nicotine Dependence","enrollment":74},{"nctId":"NCT02049073","phase":"PHASE1, PHASE2","title":"Prevention of Noise-induced Hearing Loss","status":"WITHDRAWN","sponsor":"Washington University School of Medicine","startDate":"2017-10-31","conditions":"Noise-induced Hearing Loss","enrollment":""},{"nctId":"NCT01137890","phase":"PHASE1, PHASE2","title":"Effect of Zonisamide on Cocaine Reinforcement, Craving, and Relapse","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2010-06","conditions":"Cocaine Dependence","enrollment":19},{"nctId":"NCT02727101","phase":"PHASE4","title":"Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.","status":"TERMINATED","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2015-11","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT00398918","phase":"NA","title":"Alcohol Self Administration Laboratory","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Alcoholism","enrollment":10},{"nctId":"NCT02205931","phase":"PHASE4","title":"Ketogenic Diet in Infants With Epilepsy (KIWE)","status":"UNKNOWN","sponsor":"University College, London","startDate":"2015-01","conditions":"Epilepsy","enrollment":160},{"nctId":"NCT00692003","phase":"PHASE3","title":"Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-08-01","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT01566370","phase":"PHASE2","title":"Zonisamide for Heavy Drinkers With Bipolar Disorder","status":"TERMINATED","sponsor":"Yale University","startDate":"2012-05","conditions":"Alcohol Use Disorders, Bipolar Disorder","enrollment":3},{"nctId":"NCT00275834","phase":"NA","title":"Zonisamide for Weight Reduction in Obese Adults","status":"COMPLETED","sponsor":"Duke University","startDate":"2006-01","conditions":"Obesity","enrollment":225},{"nctId":"NCT02220803","phase":"PHASE2","title":"A Short Term Open, Randomized Cross-over Trial Exploring the Effect of Carbonic Anhydrase Inhibition by Acetazolamide on Sleep Apnea Associated Hypertension and Vascular Dysfunction","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2014-03","conditions":"Obstructive Sleep Apnea, Sleep-Disordered Breathing, Blood Pressure","enrollment":13},{"nctId":"NCT01136954","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2008-07","conditions":"Partial Seizures","enrollment":144},{"nctId":"NCT00215592","phase":"PHASE4","title":"Open Label, Zonegran (Zonisamide) In Partial Onset Seizures","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2005-10","conditions":"Epilepsy","enrollment":1000},{"nctId":"NCT01546688","phase":"PHASE4","title":"A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-11","conditions":"Epilepsy","enrollment":41},{"nctId":"NCT00848549","phase":"PHASE3","title":"Assessing The Long-Term Safety And To Explore The Long-Term Efficacy Of Zonisamide As Monotherapy In Newly Diagnosed Partial Seizures","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2008-10","conditions":"Epilepsy","enrollment":295},{"nctId":"NCT00693017","phase":"PHASE3","title":"Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy","status":"TERMINATED","sponsor":"Eisai Limited","startDate":"2008-06","conditions":"Epilepsy","enrollment":10},{"nctId":"NCT00477295","phase":"PHASE3","title":"A Double-blind Study to Compare the Efficacy and Safety of Zonisamide and Carbamazepine as Monotherapy, in Newly Diagnosed Partial Epilepsy","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2007-05","conditions":"Epilepsy","enrollment":583},{"nctId":"NCT00055484","phase":"PHASE2","title":"A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache","status":"COMPLETED","sponsor":"Elan Pharmaceuticals","startDate":"2002-03","conditions":"Migraine Headache","enrollment":204},{"nctId":"NCT00047567","phase":"PHASE4","title":"Open-label Adjunctive Zonisamide for Bipolar Disorder","status":"TERMINATED","sponsor":"Elan Pharmaceuticals","startDate":"2002-07","conditions":"Bipolar Disorders","enrollment":20},{"nctId":"NCT00713622","phase":"PHASE4","title":"Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate","status":"COMPLETED","sponsor":"Eisai Limited","startDate":"2008-06","conditions":"Epilepsy","enrollment":2},{"nctId":"NCT00862563","phase":"PHASE2","title":"Interdisciplinary Study of Two Novel Anticonvulsants in Alcoholism","status":"TERMINATED","sponsor":"Boston Medical Center","startDate":"2009-05","conditions":"Alcoholism, Alcohol Dependence, Alcohol Abuse","enrollment":85},{"nctId":"NCT01806805","phase":"PHASE3","title":"Efficacy Trial of Zonisamide for Myoclonus Dystonia","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-02","conditions":"Myoclonus Dystonia","enrollment":24},{"nctId":"NCT00068770","phase":"PHASE2","title":"Celecoxib in Patients With Newly Diagnosed GBM Who Are Receiving Anticonvulsant Drugs and Undergoing RT","status":"TERMINATED","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2003-10","conditions":"Brain and Central Nervous System Tumors","enrollment":35},{"nctId":"NCT00327717","phase":"PHASE3","title":"Evaluating the Efficacy and Safety of Zonisamide in the Treatment of Partial Seizures","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2006-09","conditions":"Partial Seizures","enrollment":240},{"nctId":"NCT00616343","phase":"NA","title":"Zonisamide in the Treatment of Essential Tremor","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2003-06","conditions":"Essential Tremor","enrollment":9},{"nctId":"NCT01630057","phase":"PHASE4","title":"Evaluation of the Efficacy and Safety of Adjunctive Zonisamide vs Replacement With Zonisamide of the Last Added Antiepileptic Drug","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2009-09","conditions":"Partial Seizures","enrollment":200},{"nctId":"NCT00165828","phase":"PHASE4","title":"Efficacy and Safety of an add-on Treatment With Zonisamide in Adults With Focal Epileptic Seizures With or Without Secondary Generalization","status":"TERMINATED","sponsor":"Eisai GmbH","startDate":"2005-05","conditions":"Epilepsy","enrollment":157},{"nctId":"NCT01765608","phase":"PHASE2","title":"Zonisamide for the Treatment of Obstructive Sleep Apnea in Overweight/Obese Patients","status":"COMPLETED","sponsor":"Göteborg University","startDate":"2010-03","conditions":"Sleep Apnea, Obstructive Sleep Apnea, Obesity","enrollment":50},{"nctId":"NCT01283256","phase":"","title":"A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2011-01","conditions":"Partial, Generalized and Combined Seizures","enrollment":655},{"nctId":"NCT01587339","phase":"","title":"Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-09","conditions":"Epilepsy","enrollment":6498},{"nctId":"NCT00292461","phase":"PHASE3","title":"A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2006-03","conditions":"Epilepsy","enrollment":64},{"nctId":"NCT00659958","phase":"PHASE4","title":"ZAGAL Study: Evaluating Effectiveness and Tolerability of Zonisamide as Adjunctive Therapy in Patients With Partial Onset Seizures Treated With Two Antiepileptic Drugs","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2008-04","conditions":"Epilepsy","enrollment":32},{"nctId":"NCT00566254","phase":"PHASE3","title":"Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Study)","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2008-12","conditions":"Epilepsy; Paediatric Partial Onset Seizures","enrollment":207},{"nctId":"NCT00709371","phase":"PHASE2","title":"Zonisamide SR Plus Bupropion SR Combination Therapy in Subjects With Obesity","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2008-07","conditions":"Obesity","enrollment":729},{"nctId":"NCT00734435","phase":"PHASE2","title":"Olanzapine Given in Combination With Zonisamide SR to Prevent Weight Gain in Schizophrenic Subjects","status":"TERMINATED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2008-09","conditions":"Schizophrenia, Schizoaffective Disorder, Schizophreniform Disorder","enrollment":26},{"nctId":"NCT01390909","phase":"","title":"Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2010-05","conditions":"Epilepsy","enrollment":12386},{"nctId":"NCT00203450","phase":"PHASE4","title":"Zonegran for the Treatment of Weight Gain Associated With Psychotropic Medication Use: A Placebo-Controlled Trial","status":"COMPLETED","sponsor":"Tuscaloosa Research & Education Advancement Corporation","startDate":"2003-05","conditions":"Obesity","enrollment":20},{"nctId":"NCT01127165","phase":"PHASE4","title":"Low and High Dose Zonisamide in Children as Monotherapy","status":"COMPLETED","sponsor":"Eisai Korea Inc.","startDate":"2006-03","conditions":"Epilepsy","enrollment":125},{"nctId":"NCT00223743","phase":"PHASE2","title":"A Safety/Efficacy Trial of Zonisamide for Essential Tremor","status":"COMPLETED","sponsor":"VA Greater Los Angeles Healthcare System","startDate":"2004-11","conditions":"Essential Tremor","enrollment":25},{"nctId":"NCT00363376","phase":"PHASE3","title":"A Study of Zonisamide to Prevent Olanzapine-Associated Weight Gain","status":"COMPLETED","sponsor":"Lindner Center of HOPE","startDate":"2008-01","conditions":"Weight Gain","enrollment":42},{"nctId":"NCT00056576","phase":"PHASE3","title":"Dose Response Study of Zonegran in Patients With Newly Diagnosed Epilepsy","status":"COMPLETED","sponsor":"Eisai Inc.","startDate":"2002-02","conditions":"Epilepsy, Complex Partial","enrollment":165},{"nctId":"NCT00221442","phase":"PHASE3","title":"Zonegran in the Treatment of Binge Eating Disorder Associated With Obesity","status":"COMPLETED","sponsor":"Lindner Center of HOPE","startDate":"2005-08","conditions":"Binge Eating Disorder Associated With Obesity","enrollment":60},{"nctId":"NCT00259636","phase":"PHASE4","title":"Zonisamide for Fibromyalgia & Migraine","status":"WITHDRAWN","sponsor":"University of Pittsburgh","startDate":"2004-08","conditions":"Fibromyalgia, Migraine","enrollment":""},{"nctId":"NCT00595556","phase":"PHASE4","title":"Zonisamide vs. Placebo in the Treatment of Alcohol Dependence","status":"COMPLETED","sponsor":"UConn Health","startDate":"2006-07","conditions":"Alcoholism, Alcohol Abuse, Alcohol Dependence","enrollment":40},{"nctId":"NCT01161979","phase":"PHASE1","title":"Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fed Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-01","conditions":"Healthy","enrollment":26},{"nctId":"NCT01161966","phase":"PHASE1","title":"Bioequivalence Study of Zonisamide Capsules 100 mg of Dr.Reddy's Laboratories Limited Under Fasting Conditions","status":"COMPLETED","sponsor":"Dr. Reddy's Laboratories Limited","startDate":"2005-01","conditions":"Healthy","enrollment":26},{"nctId":"NCT00406692","phase":"PHASE2","title":"The Effects of Zonisamide on Alcohol Dependence","status":"COMPLETED","sponsor":"Boston University","startDate":"2006-11","conditions":"Alcoholism","enrollment":16},{"nctId":"NCT00685139","phase":"PHASE1","title":"Fasting Bioavailability Study of Zonisamide Capsules","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2005-01","conditions":"Healthy","enrollment":34},{"nctId":"NCT00687167","phase":"PHASE1","title":"Fed Bioavailability Study of Zonisamide Capsules","status":"COMPLETED","sponsor":"Mutual Pharmaceutical Company, Inc.","startDate":"2005-01","conditions":"Healthy","enrollment":34},{"nctId":"NCT00401973","phase":"PHASE3","title":"Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2006-11","conditions":"Schizophrenia, Schizoaffective Disorders","enrollment":199},{"nctId":"NCT00154076","phase":"PHASE4","title":"A Multicenter Comparative Trial of Zonisamide and Topiramate as Initial Monotherapy in Untreated Epilepsies","status":"COMPLETED","sponsor":"Eisai Korea Inc.","startDate":"2005-09","conditions":"Epilepsy","enrollment":140},{"nctId":"NCT00552526","phase":"PHASE4","title":"Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy","status":"UNKNOWN","sponsor":"Oslo University Hospital","startDate":"2007-11","conditions":"Epilepsy, Mental Retardation","enrollment":60},{"nctId":"NCT00298818","phase":"","title":"Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation","status":"COMPLETED","sponsor":"Northwell Health","startDate":"2002-08","conditions":"Epilepsy, Mental Retardation, Developmental Disabilities","enrollment":25},{"nctId":"NCT00339014","phase":"PHASE2","title":"Safety and Efficacy of Different Combinations of Zonisamide-CR Plus Bupropion-SR to Treat Uncomplicated Obesity","status":"COMPLETED","sponsor":"Orexigen Therapeutics, Inc","startDate":"2006-05","conditions":"Obesity","enrollment":611}],"_emaApprovals":[],"_faersSignals":[{"count":471,"reaction":"SEIZURE"},{"count":346,"reaction":"CONVULSION"},{"count":322,"reaction":"DRUG INEFFECTIVE"},{"count":238,"reaction":"FATIGUE"},{"count":210,"reaction":"HEADACHE"},{"count":209,"reaction":"SOMNOLENCE"},{"count":205,"reaction":"NAUSEA"},{"count":187,"reaction":"DIZZINESS"},{"count":152,"reaction":"FALL"},{"count":149,"reaction":"DRUG INTERACTION"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":22,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Zonegran","genericName":"Zonegran","companyName":"Dr. Reddy's Laboratories Limited","companyId":"dr-reddy-s-laboratories-limited","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}